Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Science 37 Hldgs Inc (NQ: SNCE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Mar 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Science 37 Hldgs Inc < Previous 1 2 Next > Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance May 13, 2024 Science 37’s Virtual Site Model for Clinical Research Impresses in First-of-its-Kind FDA Inspection From Science 37, Inc. Via GlobeNewswire Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation” May 09, 2024 From Science 37, Inc. Via GlobeNewswire Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial May 02, 2024 Partnership with Leading Biotech Company Enrolls 28% of Study Participants with 22x Greater Enrollment Velocity Compared to Traditional Brick-and-Mortar Clinical Trial Sites From Science 37, Inc. Via GlobeNewswire Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment April 17, 2024 New patent-protected, central recruitment leverages the Science 37 Metasite™ to accelerate enrollment and dramatically reduce site burden From Science 37, Inc. Via GlobeNewswire SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE February 27, 2024 From Kahn Swick & Foti, LLC Via Business Wire SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE February 10, 2024 From Kahn Swick & Foti, LLC Via Business Wire SNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Science 37 Holdings, Inc. Is Fair to Shareholders January 29, 2024 From Halper Sadeh LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: McGrath RentCorp (Nasdaq – MGRC), Science 37 Holdings, Inc. (Nasdaq – SNCE), Eagle Bulk Shipping Inc. (NYSE - EGLE), Cerevel Therapeutics Holdings, Inc. (Nasdaq – January 29, 2024 From Brodsky & Smith LLC Via GlobeNewswire Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment January 29, 2024 Science 37 stockholders to receive $5.75 per share in cash From Science 37, Inc. Via GlobeNewswire Science 37 Receives Top Honors in Everest PEAK Matrix® December 12, 2023 Science 37 emerges as the only clinical trial site to be recognized as a Leader in Decentralized Clinical Trials From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) December 07, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023 December 05, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) November 10, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Third Quarter 2023 Financial Results November 07, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023 October 24, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) October 06, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List September 20, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023 September 13, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan September 12, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 to Participate in H.C. Wainwright 25th Annual Global Investment Conference September 05, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Recognized as Best Digital Health Solution Nominee at 2023 Prix Galien USA Awards August 15, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) August 11, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Second Quarter 2023 Financial Results August 08, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 to Report Second Quarter 2023 Financial Results on August 8, 2023 July 25, 2023 From Science 37, Inc. Via GlobeNewswire Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU) July 11, 2023 Science 37's Metasite to Facilitate Phase 3 Study Enrollment by Expanding Access and Maximizing Convenience for Patients From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) July 07, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) June 09, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform" May 18, 2023 Science 37's unified platform that powers the Metasite receives award for outstanding digital health and technology innovation From Science 37, Inc. Via GlobeNewswire Science 37 Reports First Quarter 2023 Financial Results May 15, 2023 From Science 37, Inc. Via GlobeNewswire Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) May 05, 2023 From Science 37, Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.